Previous 10 | Next 10 |
The FDA has accepted for review a marketing application from privately held Innocoll Holdings Limited seeking approval of Xaracoll (bupivacaine hydrochloride collagen-matrix implants) for the management of postsurgical pain after inguinal (groin) hernia surgery. The agency's action date is...
CUPERTINO, Calif. , Feb. 26, 2020 /PRNewswire / -- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its fourth quarter and year ended December 31, 2019 financial results and host a conference call after the market close on Tuesday, March 3, 2020 . About DURECT...
AdaptHealth (NASDAQ: AHCO ) initiated with Buy rating and $17 (31% upside) price target at Stifel. More news on: AdaptHealth Corp., DURECT Corporation, InMed Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, , Read more ...
One Stop Systems (NASDAQ: OSS ) +56% reports prelim results . More news on: One Stop Systems, Inc., Genprex, Inc., Akcea Therapeutics, Inc., Stocks on the move, Read more ...
Gainers : CSS Industries (NYSE: CSS ) +99% . More news on: CSS Industries, Inc., NanoViricides, Inc., Novavax, Inc., Stocks on the move, , Read more ...
Aethlon Medical (NASDAQ: AEMD ) -28% on pricing equity offering. More news on: Aethlon Medical, Inc., aTyr Pharma, Inc., DURECT Corporation, Stocks on the move, , Read more ...
CUPERTINO, Calif. , Jan. 17, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) met yesterday to discuss the Class 2 New Drug Application (NDA) resub...
An FDA advisory group voted 6-6 that DURECT (NASDAQ: DRRX ) submitted enough efficacy and safety data to support approval of bupivacaine extended-release solution for the treatment of post-surgical pain. More news on: DURECT Corporation, Healthcare stocks news, Stocks on the move, Read...
CUPERTINO, Calif. , Jan. 16, 2020 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that NASDAQ has halted trading of the Company's common stock today. The U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC...
The FDA's Anesthetic and Analgesic Drug Products Advisory Committee will meet tomorrow, January 16, to review and discuss DURECT's (NASDAQ: DRRX ) marketing application for bupivacaine extended-release solution for post-surgical analgesia. More news on: DURECT Corporation, Healthcare sto...
News, Short Squeeze, Breakout and More Instantly...
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis PR Newswire DURECT plans to confirm the efficacy and safety of larsucosterol in a registrational Phase 3 clinical trial CUPERTINO, Calif. , May ...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 171.6% to $0.1657 on volume of 180,907,472 shares AMC Entertainment Holdings Inc. Class A (AMC) rose 84.4% to $9.57 on volume of 174,658,682 shares Plug Power Inc. (PLUG) rose 45.9%...
DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update PR Newswire - FDA Feedback Supports Single Pivotal Trial for Approval of Larsucosterol in Alcohol-Associated Hepatitis - Webcast of Ea...